StockWatch
·

Aarti Pharmalabs Ltd

BSE: 543748

P/L Snapshot

Q2 FY27 · standalone

vs Q1 FY27·vs Q2 FY26
Revenue
613.05
+14.1%+45.8%
Expenditure
521.74
+18.2%+37.8%
Net Profit
65.75
-7.8%+112.6%
OPM %
21.92%
-3.56pp+4.19pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.00171.65343.31514.96686.62Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Price Chart
Reports

Record growth masks rising execution risk — Xanthine guidance cut signals caution

Xanthine guidance cut · CDMO growth · working capital strain

Result verdictFollow-upQ2 FY2704 Nov 20266 minPharma & Healthcare

Record growth masks capex intensity, Xanthine guidance cut signals caution

Xanthine price normalization · CDMO 40-50% growth · Capex ₹350-400 Cr

TranscriptDeep diveQ2 FY2704 Nov 20266 minPharma & Healthcare

Can Aarti sustain momentum as capacity ramps and stamp duty clouds clarity?

API expansion · margin momentum · stamp duty headwind

Result previewQ2 FY2726 Oct 20263 minPharma & Healthcare
Latest

Corporate Events

Board MeetingAARTIPHARM
2026
28Oct

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAARTIPHARM
2026
22Sep

Board Meeting

The Company has also initiated sending letters containing th…

BSE Filing ↗
DividendAARTIPHARM
2026
15Sep

₹2 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2026
7Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing ↗
Board MeetingAARTIPHARM
2026
25May

Board Meeting

The Board Meeting was held on May 25, 2026. The agenda incl…

BSE Filing ↗
DividendAARTIPHARM
2026
16Feb

₹1.5 / share

BSE Filing ↗
DividendAARTIPHARM
2025
15Sep

₹2.5 / share

BSE Filing ↗
DividendAARTIPHARM
2025
14Feb

₹5 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2024
28Oct

Board Meeting

Audited Financial Results

BSE Filing ↗
Board MeetingAARTIPHARM
2024
13May

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗
DividendAARTIPHARM
2024
19Feb

₹2 / share

BSE Filing ↗
DividendAARTIPHARM
2024
7Feb

₹2 / share

BSE Filing ↗
Board MeetingAARTIPHARM
2024
7Feb

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗
Board MeetingAARTIPHARM
2023
7Nov

Board Meeting

Consider and approve Audited Financial Results for the quart…

BSE Filing ↗